The Importance of Non High Density Lipoprotein Cholesterol in Dyslipidaemia ManagementSubhankar Chowdhury1*, Jyothi Raman Chowdhury2 and Soumik Goswami3
- *Corresponding Author:
- Subhankar Chowdhury
Department of Endocrinology and Metabolism
IPGME & R and SSKM Hospital, 4th floor
Ronald Ross Building, 244 AJC Bose Road
Kolkata - 700020, West Bengal, India
E-mail: [email protected]
Received date: October 27, 2015; Accepted date: November 14, 2015; Published date: November 18, 2015
Citation: Chowdhury S, Chowdhury JR, Goswami S (2015) The Importance of Non High Density Lipoprotein Cholesterol in Dyslipidaemia Management. J Diabetes Metab 6:623. doi:10.4172/2155-6156.1000623
Copyright: © 2015 Chowdhury S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Dyslipidaemia is a major contributor to cardiovascular disease which has assumed epidemic proportions worldwide. The traditional approach to the management of dyslipidaemia focusses mainly on LDL cholesterol. However, recent evidence suggests that non HDL-C is an important marker of cardiovascular risk and might play a more important role than LDL cholesterol in the causation of cardiovascular disease. Non HDL cholesterol includes all ApoB containing lipoproteins and can be tested more reliably and conveniently with the available laboratory assays. Inspite of the evidence, the role of non HDL cholesterol in atherosclerosis is underrecognised and this lipid parameter is often undertreated. This review highlights the importance of non HDL cholesterol in dyslipidaemia management, both in diabetics and otherwise.